Alzheimer’s Disease Treatment Market Size and Growth Rate:

“The Global Alzheimer’s Disease Treatment Market was valued around US$ 6.1 Bn by 2018 and growing at a significant CAGR of 12.1% over next seven years 2019-2025 due to increasing occurrence of alzheimer’s disease”

Alzheimer’s Disease Treatment Market Growth Drivers and Restraints:

The global alzheimer’s disease treatment market accounted for US$ 6.1 Bn in 2018 and burgeoning over the forthcoming years. Increase in advanced diagnostics for early detection, growing occurrence of alzheimer’s disease, emerging innovative diagnostics technologies, rise in healthcare spending and R&D investments in the global alzheimer’s research, improved social awareness of the disease are some key factors influencing the market growth. However, factors such as inadequate treatment options for alzheimer’s disease and lack of government funding in emerging economies are inhibiting the market growth.

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-alzheimers-disease-treatment-market/

Cholinesterase Inhibitors dominate the Global Alzheimer’s Disease Treatment Market

Based on drug type, global alzheimer’s disease treatment market is segmented into cholinesterase inhibitors, nmda receptor antagonists and others. Cholinesterase Inhibitors held considerable market growth during estimated period. Cholinesterase inhibitors are drugs that avoid the breakdown of acetylcholine in the body. Acetylcholinesterase is an enzyme that breaks down acetylcholine to an inactive form. This decreases nerve cell communications in body that use acetylcholine to benefit transmit cell to cell messages.

Cholinesterase inhibitors block the action of acetylcholinesterase. As there will be reduced levels of acetylcholine in the brain for people with Alzheimer's, cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease as these inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.

North America Leads the Global Alzheimer’s Disease Treatment market

PBI’s global alzheimer’s disease treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global alzheimer’s disease treatment market with considerable CAGR. The growth in this region can be attributed to the existence of enhanced healthcare facilities and infrastructure in established countries, such as the U.S. Also, U.S. is the major contributor for the growth of the market in the region owing to increasing occurrence of alzheimer’s disease. For instance, according to the alzheimer's association, more than 5 million Americans suffer from Alzheimer's, as of 2017.

Strategic Partnerships are the Key Strategies Adopted by Market Players

Global alzheimer’s disease treatment market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, In January 2015, Johnson & Johnson partnered with Swiss biopharma AC Immune to develop a therapeutic vaccine for the development of anti-tau Alzheimer’s vaccine

Key player’s profiles in the report are Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Eisai Pharmaceuticals Co. Ltd. (Japan), Lundbeck A/S (Denmark), Johnson & Johnson Services Inc., (U.S.), AstraZeneca (U.K.), Pfizer Inc. (U.S.), Forest Laboratories (U.S.) and Eli Lilly and Company (U.S.).

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=15765

Detailed Segmentation of Alzheimer’s Disease Treatment Market:

By Drug Type
o Cholinesterase Inhibitors
o NMDA Receptor Antagonists
o Others

By Route of Administration
o Oral
o Implants
o Others

By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

By Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights